Ethics
This study was approved by the Ethics Committee of the Ibaraki Prefectural University of Health Sciences (approval number: 995) and was registered in the UMIN clinical trial (UMIN000049991). The experimental design was conducted in accordance with the principles of the Declaration of Helsinki. All participants provided written informed consent after adequate explanation of the conditions of participation in the study.
Participants
This study was conducted at Ibaraki Prefectural University Hospital, which had a convalescent rehabilitation ward[32]. All patients were diagnosed with stroke by their previous physician and transferred to Ibaraki Prefectural University Hospital for rehabilitation, where physical therapy, occupational therapy, and speech therapy were initiated. Patients admitted to the hospital between July 2021 and August 2022 were consecutively screened. The sample size was based on the study by Riga et al.[33], who set up an experimental design similar to this study, as there were no previous studies using the same experimental design. The inclusion and exclusion criteria for the current study were set according to those described by Tabu et al.[34]. The inclusion criteria were as follows: (1) ability to understand verbal instructions; (2) absence of any disease that interfered with task performance, such as hand pain; (3) mild motor paralysis in the paralyzed upper limb and fingers (Brunnstrom recovery stage 4 or higher); (4) ability to extend the wrist joint on the paralyzed side by 20° or more voluntarily; (5) ability to extend the proximal interphalangeal joints and metacarpophalangeal joints of the first to third fingers voluntarily by at least 10° on the paralyzed side; and (6) ability to sit independently. The exclusion criteria were as follows: (1) previous experience with a similar task, (2) orthopedic or neurological disease of the hand that interfered with daily life on the non-paralyzed side, (3) cognitive impairment (Mini Mental State Examination score < 21), (4) visual impairment (hemianopsia, diplopia, and reduced visual acuity) that prevented them from seeing the monitor, and (5) deemed unsuitable for study participation by the attending investigator.
Equipment
The grasping force was quantitatively measured using a device from iWakka (Nagoya Institute of Technology, Japan). This device consisted of a monitor, grasping device, control box, and Windows PC (Microsoft, Redmond, WA) with the iWakka Viewer application installed. The grasping device had a height of 80 mm, a diameter of 65 mm, and a weight of 0.112 kg. The force of grasping could be visualized by measuring the strain of the plate spring produced when the grasping device was opened and closed with a strain gauge, and a maximum grasping force of 0.5 kg could be measured (Fig. 4a). In previous studies, this device was used to evaluate and practice the ability to adjust the grasping force in healthy young and older adults and patients with stroke[35–38]. The sampling frequency was 10 Hz, and the spring constant of the plate spring was 4.82 × 102 N/m. The measurement environment was based on the report of Yamamoto et al[37]. Particularly, the participants placed the device on a table with an aluminum plate to reduce the effects of friction and performed the task while seated in a chair. The participants and could check the difference between the target grasping force and the measured grasping force (grasping error) reflected on the monitor as visual FB and were expected to improve their task performance by adjusting their movement for the next trial (Fig. 4b).
[Figure 4 near here]
Experimental design
This study was conducted over 2 consecutive days. The participants completed the Edinburgh Handedness Test (EHI), PRE, practice, and SRT on day 1. The LRT and visuospatial ability assessment were completed on day 2. The EHI was used to assess handedness. After EHI, the participants performed a familiarization task in which they grasped the grasping device for 10 s at a force of 0.1 kg, without viewing the monitor, for five trials. The experimental task, including familiarization, was performed using the paralyzed upper limb. The results were not provided to the participants. The experimental task started after the completion of five trials of the familiarization task.
Experimental task
Figure 5 shows the experimental tasks performed in this study. The task trial consisted of adjusting the grasping force for 30 s, 10 s for each waveform, in the order of 0.1, 0.4, and 0.25 kg target grasping force. The participants performed the task without viewing the monitor during the task trials. The trial results were provided to the participants after trial completion. FB was provided by presenting the trial results on the monitor for 10 s. A metronome (6 bpm) was used to signal the change in the target grasping force. This allowed the participants to change their adjusted grasping force in accordance with the timing of the change in the target grasping force. Specifically, the purpose of this task was to learn coordinated hand movements by trying to bring the measured grasping force as close to the target grasping force as possible, based on the tactile and motor sensations that occur when grasping devices.
[Figure 5 near here]
The test phase (PRE, SRT, and LRT) consisted of 3 trials, each without FB, and the practice phase consisted of 15 trials (5 practice blocks × 3 trials per block) with FB. The interval between trials was 10 s. For the practice trials, the next trial started 15 s after the end of the feedback period, and the interval between practice blocks was 1 min. The PRE was conducted to assess the pre-practice conditions. The SRT and LRT were conducted to assess the immediate and long-term effects of practice, respectively. The SRT was conducted 5 min after the completion of the last trial (15th trial) of the fifth practice block, and the LRT was conducted 24 h after the SRT was completed (Fig. 6).
The ROCFT is a neuropsychological assessment of visuospatial ability (visuospatial construction and memory) that consists of copy and recall trials[39]. In this study, a copy trial and a 3-min delayed-recall trial were implemented. Previous studies have shown that information is forgotten by 2–3 min after the end of the copy trial[40] and that performance does not differ between a 3-min and a 30-min delayed-recall trial in various age groups (18–74 years)[41]. Therefore, a recall trial was performed 3 min after the end of the copy trial. During the copy task, the order of descriptions was recorded using a video camera. To prevent participants from noticing the replay task, a 10-item personality test[42] was conducted between the copy and recall trials after completion of the copy trial. This prevented participants from noticing the presence of a recall trial.
[Figure 6 near here]
Measurement outcome
The Fugl–Meyer Assessment for the Upper Extremity (FMUE) and Action Research Arm Test (ARAT) were used to evaluate motor function. In a systematic review of the outcome measures of upper extremity function in patients with stroke, the FMUE was the most commonly used upper extremity function assessment tool, while the ARAT was a measure commonly used in combination with FMUE[43]. Motor function assessment was performed within 1 week prior to the start of the study. The RMSE was calculated from the absolute values of the target grasping force and the measured grasping force per unit time. A smaller RMSE thus indicated a greater ability to adjust the grasping force. We used the central 5-s interval of each target grasping force (e.g., for a 0–10-s interval, the interval from 2.5–7.5 s was used) as the analysis interval to exclude any deviation in grasping timing that occurred when the target grasping force switched.
Measurements of visuospatial ability included copy, organization, and 3-min delayed-recall scores on the ROCFT. The copy score indicated whether the participants were able to understand the form and relative position of each unit of the figure and copy it accurately. Meanwhile, the 3-min delayed-recall score indicated whether encoding of the copied figure, retention of the encoding memory, and recall of the retained memory were performed accurately. The scoring method for the copy and 3-min delayed-recall scores was based on the method of Loring et al.[44] and used a 36-point scale. The organization score indicated the organizational strategy for how the figure was segmented and described when it was depicted. The scoring method for the organization score was based on the method of Chervinsky et al.[45] and used a 36-point scale. Higher scores for each item indicated higher visuospatial ability.
Statistical analysis
First, the Shapiro–Wilk test was conducted to examine the normality of the RMSEs. Then, based on the results of the Shapiro–Wilk test, Friedman tests were conducted with the RMSE as the dependent variable and the tests (PRE, SRT, and LRT) and practice block (blocks 1–5) as factors to clarify the effects of practice and motor learning on the ability to adjust the grasping force. When significant differences were found in the Friedman test, the Wilcoxon signed-rank sum test with Holm’s correction was implemented. Next, Spearman’s rank correlation coefficients were calculated for performance on each test and motor function (FMUE, ARAT) and visuospatial ability (ROCFT) to clarify the relationship of performance on each test with motor function and visuospatial ability (copy score, organization score, and 3-min delayed-recall score). All analyses were performed using R software (version 4.3.1; R Core Team, Vienna, Austria). A p value of < 0.05 was considered statistically significant.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request ([email protected]).